Corrigendum to “Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in non-small cell lung cancer patients” [J. Pharm. Biomed. Anal. 2019 Aug 5:172:364–371]

Shaoxing Guan, Xi Chen, Fei Wang, Shuang Xin, Wei Feng, Xia Zhu, Shu Liu, Wei Zhuang, Shan Zhou, Min Huang, Xueding Wang, Li Zhang

Open source

DOI
10.1016/j.jpba.2026.117742
Published
2027-01
Container
Journal of Pharmaceutical and Biomedical Analysis
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jpba.2026.117742,
  title = {Corrigendum to “Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in non-small cell lung cancer patients” [J. Pharm. Biomed. Anal. 2019 Aug 5:172:364–371]},
  author = {Shaoxing Guan and Xi Chen and Fei Wang and Shuang Xin and Wei Feng and Xia Zhu and Shu Liu and Wei Zhuang and Shan Zhou and Min Huang and Xueding Wang and Li Zhang},
  year = {2027},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  doi = {10.1016/j.jpba.2026.117742},
  url = {https://doi.org/10.1016/j.jpba.2026.117742}
}

RIS

TY  - JOUR
TI  - Corrigendum to “Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in non-small cell lung cancer patients” [J. Pharm. Biomed. Anal. 2019 Aug 5:172:364–371]
AU  - Shaoxing Guan
AU  - Xi Chen
AU  - Fei Wang
AU  - Shuang Xin
AU  - Wei Feng
AU  - Xia Zhu
AU  - Shu Liu
AU  - Wei Zhuang
AU  - Shan Zhou
AU  - Min Huang
AU  - Xueding Wang
AU  - Li Zhang
PY  - 2027
JO  - Journal of Pharmaceutical and Biomedical Analysis
DO  - 10.1016/j.jpba.2026.117742
UR  - https://doi.org/10.1016/j.jpba.2026.117742
ER  - 

APA

Guan, S., Chen, X., Wang, F., Xin, S., Feng, W., Zhu, X., Liu, S., Zhuang, W., Zhou, S., Huang, M., Wang, X., & Zhang, L. (2027). Corrigendum to “Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in non-small cell lung cancer patients” [J. Pharm. Biomed. Anal. 2019 Aug 5:172:364–371]. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2026.117742

Source records